[go: up one dir, main page]

SI1509517T1 - Nova sinteza irbesartana - Google Patents

Nova sinteza irbesartana

Info

Publication number
SI1509517T1
SI1509517T1 SI200430833T SI200430833T SI1509517T1 SI 1509517 T1 SI1509517 T1 SI 1509517T1 SI 200430833 T SI200430833 T SI 200430833T SI 200430833 T SI200430833 T SI 200430833T SI 1509517 T1 SI1509517 T1 SI 1509517T1
Authority
SI
Slovenia
Prior art keywords
irbesartan
novel synthesis
synthesis
novel
provides
Prior art date
Application number
SI200430833T
Other languages
English (en)
Inventor
Gennady Nisnevich
Igor Rukhman
Boris Pertsikov
Julia Kaftanov
Ben-Zion Dolitzky
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of SI1509517T1 publication Critical patent/SI1509517T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SI200430833T 2003-01-16 2004-01-16 Nova sinteza irbesartana SI1509517T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US44099703P 2003-01-16 2003-01-16
PCT/US2004/001135 WO2004065383A2 (en) 2003-01-16 2004-01-16 Novel synthesis of irbesartan
EP04702955A EP1509517B1 (en) 2003-01-16 2004-01-16 Novel synthesis of irbesartan

Publications (1)

Publication Number Publication Date
SI1509517T1 true SI1509517T1 (sl) 2008-10-31

Family

ID=32771889

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200430833T SI1509517T1 (sl) 2003-01-16 2004-01-16 Nova sinteza irbesartana

Country Status (10)

Country Link
US (6) US7019148B2 (sl)
EP (3) EP2039693A3 (sl)
CN (2) CN101165062A (sl)
AT (1) ATE398121T1 (sl)
CA (1) CA2513373A1 (sl)
DE (1) DE602004014321D1 (sl)
ES (1) ES2281312T3 (sl)
PT (1) PT1509517E (sl)
SI (1) SI1509517T1 (sl)
WO (1) WO2004065383A2 (sl)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7941149B2 (en) 2002-05-13 2011-05-10 Misonimo Chi Acquistion L.L.C. Multi-hop ultra wide band wireless network communication
US7957356B2 (en) 2002-05-13 2011-06-07 Misomino Chi Acquisitions L.L.C. Scalable media access control for multi-hop high bandwidth communications
US8780770B2 (en) * 2002-05-13 2014-07-15 Misonimo Chi Acquisition L.L.C. Systems and methods for voice and video communication over a wireless network
CN101165062A (zh) * 2003-01-16 2008-04-23 特瓦制药工业有限公司 伊贝沙坦的新合成方法
DE602004015071D1 (de) 2003-02-05 2008-08-28 Teva Pharma Synthese von 2-butyl-3-(2'-(1-trityl-1h-tetrazol-5-yl)biphenyl-4-yl)-1,3-diazaspiro-4,4 -nonen-4-on
EP1751123A4 (en) * 2004-05-20 2010-06-30 Reddys Lab Ltd Dr PROCESS FOR PREPARING IRBESARTAN
TWI346108B (en) * 2004-08-23 2011-08-01 Bristol Myers Squibb Co A method for preparing irbesartan and intermediates thereof
DE102004060699A1 (de) * 2004-12-16 2006-06-22 Ratiopharm Gmbh Verfahren zur Herstellung von Candesartan
PT1833801E (pt) * 2004-12-22 2008-08-25 Algry Quimica S L Compostos intermediários para a preparação de antagonistas do receptor da angiotensina ii
SI21965A (sl) * 2005-01-05 2006-08-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Priprava tetrazolskega derivata
ES2259909B1 (es) * 2005-02-28 2007-06-16 Inke, S.A. Procedimiento para la obtencion de un compuesto farmaceuticamente activo y de su intermedio de sintesis.
WO2006125592A2 (en) * 2005-05-24 2006-11-30 Lek Pharmaceuticals D.D. Process for the preparation of 2-alkyl-1-((2'-substituted-biphenyl-4-yl)methyl)-imidazole, dihydroimidazole or benzimidazole derivatives
EP1749828A1 (en) 2005-08-04 2007-02-07 Farmaprojects S.L. Process for preparing an angiotensin II receptor antagonist
EP1764365A1 (en) * 2005-09-20 2007-03-21 KRKA, D.D., Novo Mesto A process for the preparation of sartan derivates and intermediates useful in such process
EP1948641A1 (en) 2005-10-28 2008-07-30 Alembic Limited An improved process for preparation of irbesartan
ES2300175B1 (es) * 2006-02-14 2009-06-08 Inke, S.A. Procedimiento para la obtencion de intermedios utiles en la obtencion de un compuesto farmaceuticamente activo.
SI2016073T1 (sl) 2006-04-07 2011-12-30 Lek Pharmaceuticals D.D. Postopek za pripravo ÄŤistega irbesartana
US8175613B2 (en) 2006-08-04 2012-05-08 Misonimo Chi Acquisitions L.L.C. Systems and methods for determining location of devices within a wireless network
US20080103312A1 (en) * 2006-08-29 2008-05-01 Kansal Vinod K Processes for the synthesis of 5-phenyl-1-trityl-1H-tetrazole
EP2092664A4 (en) * 2006-12-07 2013-10-16 Misonimo Chi Acquisition L L C SYSTEMS AND METHODS FOR TIME WINDOW AND CHANNEL ALLOCATION
CA2759163C (en) 2009-04-28 2015-02-17 Daiichi Sankyo Company, Limited Method for producing olmesartan medoxomil
CN106608886A (zh) * 2015-11-22 2017-05-03 宁夏际华环境安全科技有限公司 一种苯基硼酸生产工艺

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US531929A (en) * 1895-01-01 harden
GB8910547D0 (en) * 1989-05-08 1989-06-21 Ici America Inc Substituted ketones
US5270317A (en) 1990-03-20 1993-12-14 Elf Sanofi N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present
US5164403A (en) * 1991-04-05 1992-11-17 G. D. Searle & Co. N-arylheteroarylalkyl imidazol-2-one compounds for treatment of circulatory disorders
JPH06510763A (ja) * 1991-08-19 1994-12-01 イー・アイ・デュポン・ドゥ・ヌムール・アンド・カンパニー アンジオテンシン２受容体遮断イミダゾリノン誘導体
US5310929A (en) * 1992-08-06 1994-05-10 E. I. Du Pont De Nemours And Company Prodrugs of imidazole carboxylic acids as angiotensin II receptor antagonists
EP0669830A4 (en) * 1992-11-06 1997-02-26 Merck & Co Inc SUBSTITUTED DIPEPTIDE ANALOGS PROMOTING THE RELEASE OF GROWTH HORMONE.
US5541209A (en) * 1994-08-22 1996-07-30 Bristol-Myers Squibb Company Method of treating or preventing cardiac arrhythmia employing an N-substituted heterocyclic derivative
WO1996009301A1 (fr) * 1994-09-20 1996-03-28 Wakunaga Seiyaku Kabushiki Kaisha Procede de production d'un derive de n-biphenylmethylthiadiazoline ou un sel de celui-ci et son intermediaire de production
FR2725987B1 (fr) 1994-10-19 1997-01-10 Sanofi Sa Procede pour la preparation d'un derive de tetrazole sous deux formes cristallines et nouvelle forme cristalline de ce derive
US5541204A (en) * 1994-12-02 1996-07-30 Bristol-Myers Squibb Company Aryloxypropanolamine β 3 adrenergic agonists
IT1292437B1 (it) * 1997-06-30 1999-02-08 Zambon Spa Processo di orto-metallazione utile per la sintesi di 1 - tetrazol- 5-il) benzeni 2-sostituiti
FR2780403B3 (fr) * 1998-06-24 2000-07-21 Sanofi Sa Nouvelle forme de l'irbesartan, procedes pour obtenir ladite forme et compositions pharmaceutiques en contenant
AU2003256609A1 (en) 2002-07-16 2004-02-02 Teva Pharmaceutical Industries Ltd. Novel synthesis of irbesartan
CN101165062A (zh) * 2003-01-16 2008-04-23 特瓦制药工业有限公司 伊贝沙坦的新合成方法

Also Published As

Publication number Publication date
CN1759113A (zh) 2006-04-12
WO2004065383A3 (en) 2004-12-16
CN101165062A (zh) 2008-04-23
WO2004065383A2 (en) 2004-08-05
US20060135544A1 (en) 2006-06-22
EP1509517B1 (en) 2008-06-11
US7227026B2 (en) 2007-06-05
US20060128968A1 (en) 2006-06-15
ES2281312T3 (es) 2008-08-01
US7301035B2 (en) 2007-11-27
ES2281312T1 (es) 2007-10-01
EP2039693A3 (en) 2009-06-17
US20090216026A1 (en) 2009-08-27
PT1509517E (pt) 2008-08-05
US7838683B2 (en) 2010-11-23
EP2189457A1 (en) 2010-05-26
EP1509517A2 (en) 2005-03-02
US7019148B2 (en) 2006-03-28
CA2513373A1 (en) 2004-08-05
US20060135780A1 (en) 2006-06-22
DE602004014321D1 (de) 2008-07-24
EP2039693A2 (en) 2009-03-25
US20040192713A1 (en) 2004-09-30
US7217825B2 (en) 2007-05-15
US20070213539A1 (en) 2007-09-13
ATE398121T1 (de) 2008-07-15

Similar Documents

Publication Publication Date Title
SI1509517T1 (sl) Nova sinteza irbesartana
HK1157334A1 (en) Process for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3- benzazepine hydrochloride hemihydrate (r)-8--1--2345--1h-3-
ZA200307450B (en) Process for the production of synthesis gas.
IL175390A0 (en) Parocess for the preparation of telmisartan
HK1145322A1 (sl)
PT1592793E (pt) Compostos oligoméricos para a modulação da expressão de survivina
IL175253A0 (en) A process for preparing pyrrole derivatives
TW200617019A (en) A process for the preparation of 7α-alkylated 19-norsteroids
GB0504952D0 (en) Process for producing arylamine
MXPA03006322A (es) Procedimiento mejorado para la sintesis de carbapenem.
TW200637832A (en) Process for preparing amorphous valsartan
MXPA03004986A (es) Proceso para preparar polimeros de emulsion con alta pureza.
PL1680430T3 (pl) Sposoby wytwarzania postaci i (s)-(+)-wodorosiarczanu klopidogrelu
ZA200602149B (en) Process for the synthesis of 6-amino-4-[(3-chloro-4-fluo-rophenyl)amino]-7-ethoxy-quinoline-3-carbonitrile
TW200510376A (en) Process for preparing (s)-pantoprazole
SI1403264T1 (sl) Postopek za industrijsko proizvodnjo 5-amino-3-karboksimetil-4-ciano-2- tiofenkarboksi-dimetilestra
EP1598389A4 (en) METHOD FOR PRODUCING A CATIONICALLY HARDENABLE SILICONE COMPOUND
AU2003276330A8 (en) Novel compounds comprising a thiocarbonyl-sulfanyl group, which can be used for the radical synthesis of alpha-perfluoroalkylamines
TW200407314A (en) Preparation of 4, 6-dichloro-5-fluoropyrimidine
TWI319707B (en) Method of purifying pravastatin
EG24122A (en) Process for the synthesis of 3-cyano-6-alkoxy-7-nitro-4-quinolines
AU2003303563A1 (en) Process for synthesizing amine from nitrile
IL166374A0 (en) Novel process for producing imidazoÄ1,2-bÜpyridazine derivative
AU2003302339A1 (en) Process for synthesizing amine from nitrile
MXPA05009152A (es) Preparacion de k-252a.